Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
Neogen Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Neogen wird ein Gewinn- und Umsatzwachstum von 123.4% bzw. 2.6% pro Jahr prognostiziert, während der Gewinn pro Aktie um 122.8% pro Jahr wachsen soll.
Wichtige Informationen
123.4%
Wachstumsrate der Gewinne
122.8%
EPS-Wachstumsrate
| Medical Equipment Gewinnwachstum | 16.6% |
| Wachstumsrate der Einnahmen | 2.6% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 15 Apr 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Apr 12
Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Jan 12Recent updates
There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price
May 21Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust
Apr 15Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Apr 12Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt
Mar 29Neogen: All About Execution From Here On
Mar 26Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are
Jan 17Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Jan 12Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected
Jan 09Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly
Dec 06Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Jul 12Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?
Jun 20Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Mar 25Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use
Oct 10Neogen GAAP EPS of $0.05, revenue of $132.35M
Sep 27Neogen drops 9% as merger with 3M’s food safety business closes
Sep 01Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher
Aug 21Neogen: Cut In Half, Still Some Questions
Aug 12There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings
Aug 04Neogen: Thesis Unchanged After Q4 And Full-Year Earnings
Aug 01Neogen FQ4 2022 Earnings Preview
Jul 25Zoetis, IDEXX named as buys in animal health space by Piper Sandler
Jul 13Neogen announces pricing of $350M senior notes offering
Jul 07Neogen: Safety Food Giant In The Making
Dec 15Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends
Dec 12Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends
Sep 12Robust Valuation Leaves Neogen Little Room For Error After Mixed Results
Jul 27Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 5/31/2026 | 978 | 22 | N/A | N/A | 2 |
| 5/31/2025 | 938 | 3 | N/A | N/A | 2 |
| 5/31/2024 | 912 | -8 | N/A | N/A | 2 |
| 2/29/2024 | 929 | 2 | -13 | 99 | N/A |
| 11/30/2023 | 919 | 12 | 17 | 113 | N/A |
| 8/31/2023 | 919 | -27 | -5 | 78 | N/A |
| 5/31/2023 | 822 | -23 | -25 | 41 | N/A |
| 2/28/2023 | 721 | -13 | -82 | -30 | N/A |
| 11/30/2022 | 631 | -16 | -50 | -6 | N/A |
| 8/31/2022 | 531 | 36 | -5 | 31 | N/A |
| 5/31/2022 | 527 | 48 | 44 | 68 | N/A |
| 2/28/2022 | 514 | 49 | 50 | 70 | N/A |
| 11/30/2021 | 503 | 57 | 54 | 75 | N/A |
| 8/31/2021 | 487 | 62 | 55 | 79 | N/A |
| 5/31/2021 | 468 | 61 | 54 | 81 | N/A |
| 2/28/2021 | 450 | 61 | 58 | 85 | N/A |
| 11/30/2020 | 433 | 60 | 71 | 93 | N/A |
| 8/31/2020 | 426 | 61 | 65 | 87 | N/A |
| 5/31/2020 | 418 | 59 | 62 | 86 | N/A |
| 2/29/2020 | 419 | 59 | 62 | 81 | N/A |
| 11/30/2019 | 417 | 60 | 51 | 72 | N/A |
| 8/31/2019 | 416 | 60 | 52 | 71 | N/A |
| 5/31/2019 | 414 | 60 | 49 | 64 | N/A |
| 2/28/2019 | 413 | 62 | 49 | 66 | N/A |
| 11/30/2018 | 410 | 65 | 57 | 74 | N/A |
| 8/31/2018 | 403 | 66 | 48 | 67 | N/A |
| 5/31/2018 | 398 | 63 | 48 | 69 | N/A |
| 2/28/2018 | 389 | 58 | 44 | 62 | N/A |
| 11/30/2017 | 382 | 52 | N/A | 58 | N/A |
| 8/31/2017 | 372 | 46 | N/A | 59 | N/A |
| 5/31/2017 | 358 | 44 | N/A | 60 | N/A |
| 2/28/2017 | 353 | 41 | N/A | 53 | N/A |
| 11/30/2016 | 341 | 39 | N/A | 44 | N/A |
| 8/31/2016 | 330 | 37 | N/A | 49 | N/A |
| 5/31/2016 | 321 | 37 | N/A | 35 | N/A |
| 2/29/2016 | 310 | 36 | N/A | 38 | N/A |
| 11/30/2015 | 301 | 35 | N/A | 41 | N/A |
| 8/31/2015 | 290 | 34 | N/A | 40 | N/A |
| 5/31/2015 | 283 | 34 | N/A | 44 | N/A |
| 2/28/2015 | 272 | 32 | N/A | 38 | N/A |
| 11/30/2014 | 265 | 31 | N/A | 34 | N/A |
| 8/31/2014 | 256 | 29 | N/A | 27 | N/A |
| 5/31/2014 | 247 | 28 | N/A | 22 | N/A |
| 2/28/2014 | 236 | 28 | N/A | 24 | N/A |
| 11/30/2013 | 225 | 28 | N/A | 26 | N/A |
| 8/31/2013 | 216 | 28 | N/A | 28 | N/A |
| 5/31/2013 | 208 | 27 | N/A | 27 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: NEOG's forecast earnings growth (123.4% per year) is above the savings rate (2.4%).
Ertrag vs. Markt: NEOGDie Erträge des Unternehmens (123.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.7% pro Jahr).
Hohe Wachstumserträge: NEOGEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: NEOG's revenue (2.6% per year) is forecast to grow slower than the US market (8.4% per year).
Hohe Wachstumseinnahmen: NEOGDie Einnahmen des Unternehmens (2.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von NEOG in 3 Jahren voraussichtlich hoch sein wird